Publication | Closed Access

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

Breast OncologyOncologyAnthracycline FailureSequential MethotrexateBreast CancerPharmacotherapyCancer TreatmentMedicineRadiation OncologyScandinavian Breast Group